CellSeed Inc. (TYO:7776)

Japan flag Japan · Delayed Price · Currency is JPY
555.00
-28.00 (-4.80%)
Apr 28, 2025, 3:30 PM JST
160.56%
Market Cap 19.24B
Revenue (ttm) 161.00M
Net Income (ttm) -914.00M
Shares Out 34.67M
EPS (ttm) -53.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,481,900
Average Volume 3,054,175
Open 583.00
Previous Close 583.00
Day's Range 552.00 - 584.00
52-Week Range 209.00 - 1,160.00
Beta 0.94
RSI 52.91
Earnings Date May 13, 2025

About CellSeed

CellSeed Inc. develops cell sheet regenerative medicines. It is involved in the research, development, and commercialization of cell-sheet regenerative medicine products, such as epithelial cell sheet for esophageal regeneration, regenerated cartilage sheet, and chondrocyte sheet for the treatment of knee osteoarthritis. The company also offers UpCell, a temperature-responsive cell cultureware for cell-sheet engineering; RepCell, a temperature-responsive cell cutureware for cell collection; and HydroCell, a low cell binding cultureware. In addi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 44
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7776
Full Company Profile

Financial Performance

In 2021, CellSeed's revenue was 161.00 million, a decrease of -19.10% compared to the previous year's 199.00 million. Losses were -914.00 million, 16.7% more than in 2020.

Financial Statements

News

There is no news available yet.